TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Lifemd, Inc.
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

LifeMD announced lower cash-pay pricing for Wegovy and Ozempic medications at $199 per month, supporting patients paying out of pocket through its Weight Management Program in collaboration with Novo Nordisk.

Insights
SHW   positive

Industry-leading paint and coatings company, 46-year dividend growth, technology-resistant business model


LFMD   positive

Expanding affordable medication access, strengthening pharmaceutical partnerships, and positioning itself strategically in the weight management healthcare market